Anderson Medical Research
Clinical research site in Ft. Washington, Maryland
As of July 2026, 6 paid clinical trials are recruiting at Anderson Medical Research in Ft. Washington, Maryland. Active studies at this site cover conditions such as Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation (AF) and Cardiovascular Disease and Lipoprotein(a). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Anderson Medical Research (6)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Get new-trial alerts for Anderson Medical Research
We'll email you whenever a new clinical trial starts recruiting at this research site in Ft. Washington, MD. Unsubscribe anytime.
More research sites in Ft. Washington
- Anderson Medical Group (1 trial)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Ft. Washington, MD · Maryland clinical trials